Anti-CLPS antibody (18-112)

Cat# NB-22-22839-200

Size : 200uL(2x100uL)

Request more information

Contact local distributor :


Phone : +1 850 650 7790

  • Western blot analysis of extracts of mouse pancreas, using CLPS antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 30s.

General Info

Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CLPS (18-112) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.

Information

Gene Symbol: CLPS
Gene ID: 1208
Uniprot ID: COL_HUMAN
Immunogen Region: 18-112
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 18-112 of human CLPS (NP_001823.1).
Immunogen Sequence: APGPRGIIINLENGELCMNS AQCKSNCCQHSSALGLARCT SMASENSECSVKTLYGIYYK CPCERGLTCEGDKTIVGSIT NTNFGICHDAGRSKQ

Description

Tissue Specificity Expressed by the pancreas.
Function Colipase is a cofactor of pancreatic lipase. It allows the lipase to anchor itself to the lipid-water interface. Without colipase the enzyme is washed off by bile salts, which have an inhibitory effect on the lipase. Enterostatin has a biological activity as a satiety signal.
Protein Name Colipase
Database Links Reactome: R-HSA-192456
Reactome: R-HSA-975634
Cellular Localisation Secreted
Alternative Antibody Names Anti-Colipase antibody
Anti-CLPS antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance